YB
Publications
27
Views
11 528
Downloads
1 373
Supervised works
0
Items per page
1 - 27 of 27
Title Published in Access level OA Policy Year Views Downloads
Myeloproliferative neoplasms in young patients: clinical features and specific management
accessLevelRestricted
2024 84 5
Low plasma levels of hyaluronic acid might rule out sinusoidal obstruction syndrome after hematopoietic stem cell transplantationDisease markers
accessLevelPublic
2023 16 5
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsBlood advances
accessLevelPublic
2022 27 12
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective StudyTransplantation and cellular therapy
accessLevelPublic
2022 75 35
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graftBone marrow transplantation
accessLevelRestricted
2021 250 0
A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic AttackActa Haematologica
accessLevelPublic
2020 283 208
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiencyEuropean Journal of Haematology
accessLevelPublic
2020 257 114
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsBiology of Blood and Marrow Transplantation
accessLevelPublic
2020 252 166
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationLeukemia and Lymphoma
accessLevelRestricted
2018 476 2
Validation de l'index de risque lié à la pathologie chez les patients ayant bénéficié d'une allogreffe de cellules souches hématopoïétiques partiellement déplétée en lymphocytes T in vitro
accessLevelRestricted
2018 551 6
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndromeBone Marrow Transplantation
accessLevelRestricted
2018 382 0
FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remissionHematological oncology
accessLevelRestricted
2017 505 3
Thromboses veineuses splanchniquesRevue médicale suisse
accessLevelPublic
2017 379 113
Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemiaHaemophilia
accessLevelRestricted
2017 477 4
Pegylated interferon alpha-2a for essential thrombocythaemia during pregnancy, outcome and safety: a case seriesHaematologica
accessLevelRestricted
2016 357 0
Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?Future oncology
accessLevelRestricted
2016 491 3
Complete remission of disseminated granulomatous dermatitis related to chronic eosinophilic leukemia following allogeneic stem cell transplantationLeukemia & lymphoma
accessLevelRestricted
2016 1 163 1
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk indexBone marrow transplantation
accessLevelRestricted
2016 584 2
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplantsBone marrow transplantation
accessLevelRestricted
2016 612 4
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosisBritish journal of haematology
accessLevelRestricted
2016 451 0
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal studyNeurology® neuroimmunology & neuroinflammation
accessLevelPublic
2015 440 288
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?Platelets
accessLevelRestricted
2015 626 3
Pacritinib: a new agent for the management of myelofibrosis?Expert opinion on pharmacotherapy
accessLevelRestricted
2015 450 2
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletionBiology of blood and marrow transplantation
accessLevelRestricted
2014 525 1
Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuationInternational journal of hematology
accessLevelRestricted
2014 474 0
Surveillance biologique des héparines et du fondaparinuxRevue médicale suisse
accessLevelRestricted
2011 543 4
A body-packer with a cocaine bag stuck in the stomachWorld journal of radiology
accessLevelPublic
2011 798 392
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack